Saluda Medical earned FDA approval for its biomarker-based automated patient programming platform used in spinal cord stimulation.

Saluda Medical has completed a $100m financing ... The platform claims to operate by delivering spinal cord stimulation (SCS) therapy that senses and measures neural activation, with an aim ...

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Saluda is empowering clinicians to deliver ... and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation ...